@article{ajmcr20175124,
author={{H, Yasin and M, Mathews and J, Suh and D, Finkel},
title={Acute Kidney Injury Associated with Sofosbuvir-Simeprevir in a Patient with Chronic Hepatitis C Virus Infection and HIV Infection: A Case Report},
journal={American Journal of Medical Case Reports},
volume={5},
number={12},
pages={298--300},
year={2017},
url={http://pubs.sciepub.com/ajmcr/5/12/4},
issn={2374-216X},
abstract={Sofosbuvir and Simeprevir are new antiviral agents that have been used to treat chronic hepatitis C virus infection in the recent years with excellent virological response. Both agents are considered to have a safe renal profile. We present a 57-year-old male patient with chronic hepatitis c virus infection who developed acute kidney injury requiring hemodialysis after 7 weeks from beginning of Sofosbuvir and Simeprevir regimen. There was no renal side effects reported in clinical trials of both agents and There was only one reported case of kidney injury in patient taking Sofosbuvir in combination with Ledipasvir.},
doi={10.12691/ajmcr-5-12-4}
publisher={Science and Education Publishing}
}